191 related articles for article (PubMed ID: 17113468)
1. Cognitive functions in brain tumor patients.
Correa DD
Hematol Oncol Clin North Am; 2006 Dec; 20(6):1363-76. PubMed ID: 17113468
[TBL] [Abstract][Full Text] [Related]
2. Cognitive functioning and quality of life in malignant glioma patients: a review of the literature.
Weitzner MA; Meyers CA
Psychooncology; 1997 Sep; 6(3):169-77. PubMed ID: 9313282
[TBL] [Abstract][Full Text] [Related]
3. Interventions for cognitive deficits in patients with a brain tumor: an update.
Gehring K; Aaronson NK; Taphoorn MJ; Sitskoorn MM
Expert Rev Anticancer Ther; 2010 Nov; 10(11):1779-95. PubMed ID: 21080804
[TBL] [Abstract][Full Text] [Related]
4. Therapy-induced plasticity of cognitive functions in MS patients: insights from fMRI.
Penner IK; Kappos L; Rausch M; Opwis K; Radü EW
J Physiol Paris; 2006 Jun; 99(4-6):455-62. PubMed ID: 16713204
[TBL] [Abstract][Full Text] [Related]
5. Cognitive function of patients with brain tumor in pre- and postoperative stage.
Yoshii Y; Tominaga D; Sugimoto K; Tsuchida Y; Hyodo A; Yonaha H; Kushi S
Surg Neurol; 2008 Jan; 69(1):51-61; discussion 61. PubMed ID: 18054616
[TBL] [Abstract][Full Text] [Related]
6. Cognitive outcome in pediatric brain tumor survivors: delayed attention deficit at long-term follow-up.
Brière ME; Scott JG; McNall-Knapp RY; Adams RL
Pediatr Blood Cancer; 2008 Feb; 50(2):337-40. PubMed ID: 17458873
[TBL] [Abstract][Full Text] [Related]
7. [Neurocognitive deficits in patients with malignant brain tumors].
Dinkel A; Geinitz H; Ringel F; Herschbach P
Psychother Psychosom Med Psychol; 2012; 62(3-4):89-94. PubMed ID: 22473426
[TBL] [Abstract][Full Text] [Related]
8. Cognitive function and quality of life in ovarian cancer.
Correa DD; Hess LM
Gynecol Oncol; 2012 Mar; 124(3):404-9. PubMed ID: 22094932
[TBL] [Abstract][Full Text] [Related]
9. The impact of personality characteristics on the clinical expression in neurodegenerative disorders--a review.
von Gunten A; Pocnet C; Rossier J
Brain Res Bull; 2009 Oct; 80(4-5):179-91. PubMed ID: 19616079
[TBL] [Abstract][Full Text] [Related]
10. Neurocognitive and quality of life measures in patients with metastatic brain disease.
Witgert ME; Meyers CA
Neurosurg Clin N Am; 2011 Jan; 22(1):79-85, vii. PubMed ID: 21109152
[TBL] [Abstract][Full Text] [Related]
11. Cognitive dysfunction evaluation in multiple sclerosis patients treated with interferon beta-1b: an open-label prospective 1 year study.
Flechter S; Vardi J; Finkelstein Y; Pollak L
Isr Med Assoc J; 2007 Jun; 9(6):457-9. PubMed ID: 17642394
[TBL] [Abstract][Full Text] [Related]
12. [Cognitive disorders and adult grade II and III gliomas: analysis of a series of 15 patients].
Le Rhun E; Delbeuck X; Devos P; Pasquier F; Dubois F
Neurochirurgie; 2009 Jun; 55(3):303-8. PubMed ID: 18822437
[TBL] [Abstract][Full Text] [Related]
13. Surviving glioblastoma for more than 5 years: the patient's perspective.
Steinbach JP; Blaicher HP; Herrlinger U; Wick W; Nägele T; Meyermann R; Tatagiba M; Bamberg M; Dichgans J; Karnath HO; Weller M
Neurology; 2006 Jan; 66(2):239-42. PubMed ID: 16434662
[TBL] [Abstract][Full Text] [Related]
14. Detrimental effects of tumor progression on cognitive function of patients with high-grade glioma.
Brown PD; Jensen AW; Felten SJ; Ballman KV; Schaefer PL; Jaeckle KA; Cerhan JH; Buckner JC
J Clin Oncol; 2006 Dec; 24(34):5427-33. PubMed ID: 17135644
[TBL] [Abstract][Full Text] [Related]
15. Prospective evaluation of quality of life and neurocognitive effects in patients with multiple brain metastases receiving whole-brain radiotherapy with or without thalidomide on Radiation Therapy Oncology Group (RTOG) trial 0118.
Corn BW; Moughan J; Knisely JP; Fox SW; Chakravarti A; Yung WK; Curran WJ; Robins HI; Brachman DG; Henderson RH; Mehta MP; Movsas B
Int J Radiat Oncol Biol Phys; 2008 May; 71(1):71-8. PubMed ID: 18164829
[TBL] [Abstract][Full Text] [Related]
16. Cognitive rehabilitation in patients with gliomas: a randomized, controlled trial.
Gehring K; Sitskoorn MM; Gundy CM; Sikkes SA; Klein M; Postma TJ; van den Bent MJ; Beute GN; Enting RH; Kappelle AC; Boogerd W; Veninga T; Twijnstra A; Boerman DH; Taphoorn MJ; Aaronson NK
J Clin Oncol; 2009 Aug; 27(22):3712-22. PubMed ID: 19470928
[TBL] [Abstract][Full Text] [Related]
17. Brain metastases: current management and new developments.
Soffietti R; Rudà R; Trevisan E
Curr Opin Oncol; 2008 Nov; 20(6):676-84. PubMed ID: 18841050
[TBL] [Abstract][Full Text] [Related]
18. The use of the mini-mental state examination to assess cognitive functioning in cancer trials: no ifs, ands, buts, or sensitivity.
Meyers CA; Wefel JS
J Clin Oncol; 2003 Oct; 21(19):3557-8. PubMed ID: 12913103
[No Abstract] [Full Text] [Related]
19. Evaluation of cognitive functions and quality of life.
Taphoorn MJ; Klein M
Handb Clin Neurol; 2012; 104():173-83. PubMed ID: 22230444
[No Abstract] [Full Text] [Related]
20. Cognitive deficits and predictors 3 years after diagnosis of a pilocytic astrocytoma in childhood.
Aarsen FK; Paquier PF; Arts WF; Van Veelen ML; Michiels E; Lequin M; Catsman-Berrevoets CE
J Clin Oncol; 2009 Jul; 27(21):3526-32. PubMed ID: 19433687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
